---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-103727"
form_type: "8-K"
ticker: "ENGN"
cik: "0001980845"
company_name: "enGene Therapeutics Inc."
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:19:28.695316+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# enGene Holdings updates corporate presentation; no specific operational or financial changes disclosed

## Summary
- Corporate presentation dated September 5, 2024 furnished as Exhibit 99.1.
- Presentation titled 'Non-Viral Genetic Medicine' — no new pipeline or financial data provided in this filing.
- No material events such as earnings, leadership changes, or financing announced.

## SEC filing metadata
- accession: 0000950170-24-103727
- form_type: 8-K
- ticker: ENGN
- cik: 0001980845
- company_name: enGene Therapeutics Inc.
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1980845/000095017024103727/0000950170-24-103727-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1980845/000095017024103727/engn-20240905.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-103727
- JSON: https://secwatch.observer/filing/0000950170-24-103727.json
- Plain text: https://secwatch.observer/filing/0000950170-24-103727.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.